Burjeel Holdings and Response Plus Launch $1 Million Human Energy Health Award at ADIPEC 2024Burjeel Holdings, a leading super-specialty healthcare provider in the MENA region, and Response Plus Medical Services (RPM), the largest pre-hospital care and emergency medical services provider…
Inocras Inc. (San Diego, CA; President & CEO: Jehee Suh) and Summit Pharmaceuticals International Corporation (Tokyo, Japan; President & CEO: Katsuya Okuyama) have signed a Memorandum of Understanding (MOU) to explore the commercialization of their whole genome sequencing (WGS) analysis…
Endologix LLC, a global leader in medical devices for vascular disease, today revealed the final 36-month results of its DETOUR2 Study. The DETOUR System provides an innovative solution for treating complex peripheral arterial disease (PAD) by enabling physicians to bypass…
Fusion Orthopedics, LLC has secured a major victory against Extremity Medical, LLC following a ruling by the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board (PTAB). The PTAB invalidated 14 claims of U.S. Patent No. 11,298,166 (the ‘166…
MaaT Pharma (EURONEXT: MAAT), a clinical-stage biotech leader in developing microbiome-based therapies for cancer, today provided an update on its activities and financial performance for the third quarter of 2024, as well as key developments in its management team. Clinical…
e4life, a joint venture formed by two global leaders—ELT Group, a world leader in electronic defense, and Lendlease, experts in large-scale urban regeneration—will present its e4shield™ technology at MEDICA 2024. The prestigious event, which serves as a key gathering for…
Anumana, a leading AI-driven health technology company, announced that the Centers for Medicare & Medicaid Services (CMS) has recognized its low ejection fraction (LEF) ECG-AI™ technology in the 2025 Hospital Outpatient Prospective Payment System (OPPS) final rule under APC 5734.…
Genmab A/S (Nasdaq: GMAB) today announced that over 20 abstracts evaluating epcoritamab-bysp (EPKINLY®), a subcutaneously administered T-cell engaging bispecific antibody, will be presented at the 66th Annual Meeting of the American Society of Hematology (ASH), taking place December 7-10, 2024,…
ELIQUENT Life Sciences, a global regulatory consulting firm, is pleased to announce the addition of Shelley Gandhi, a renowned pharmacovigilance (PV) expert, to its team. This strategic hire strengthens ELIQUENT’s leadership in regulatory and quality services and underscores the firm’s…
Immunis, Inc., a clinical-stage biotechnology company focused on developing innovative secretomes for age-related diseases and immune dysfunction, has launched non-terminal safety studies for canine muscle atrophy in collaboration with VetBio Partners, LLC. This follows the successful preclinical results of Immunis’…
LumiThera Inc., a medical device company specializing in photobiomodulation (PBM) therapy for ocular conditions, today announced that the U.S. Food and Drug Administration (FDA) has granted marketing authorization for its Valeda® Light Delivery System. The system is approved for the…
GeneDx (Nasdaq: WGS), a leader in leveraging genomic insights to improve health outcomes, today announced its scientific contributions for the 2024 American Society of Human Genetics (ASHG) Annual Meeting. GeneDx will present data across six platform sessions and five posters,…